Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

Gray, Madison T, Woulfe, John M·2015·Journal of Cerebral Blood Flow & Metabolism

DOI 10.1038/jcbfm.2015.32

Cited by (409)

Items 101–200 of 409

Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity
Juhyun Song, Seong‐Min Choi, Daniel J. Whitcomb, Byeong Chae Kim · 2017 · Cell Death and Disease
Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives
Federica Ferrari, Antonio Moretti, Roberto Federico Villa · 2022 · Pharmacology & Therapeutics
Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson’s Disease
Robert Powers, Shulei Lei, Annadurai Anandhan, Darrell D. Marshall, Bradley Worley, Ronald L. Cerny, Eric D. Dodds, Yuting Huang, Mihalis I. Panayiotidis, Aglaia Pappa et al. · 2017 · Metabolites
Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson’s Disease
Shi-Xun Ma, Bo Am Seo, Donghoon Kim, Yulan Xiong, Seung‐Hwan Kwon, Saurav Brahmachari, Sangjune Kim, Tae‐In Kam, Raja Sekhar Nirujogi, Sang Ho Kwon et al. · 2021 · Journal of Proteome Research
Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment
Yixuan Liang, Li Cui, Jiguo Gao, Mingqin Zhu, Ying Zhang, Hongliang Zhang · 2021 · Molecular Neurobiology
High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
Osama F. Elabi, João Paulo Monteiro Carvalho Móri da Cunha, Abderahim Gaceb, Malin Fex, Gesine Paul · 2021 · Journal of Neuroinflammation
Blood–brain barrier opening with focused ultrasound in experimental models of Parkinson's disease
Maria Eleni Karakatsani, Javier Blesa, Elisa E. Konofagou · 2019 · Movement Disorders
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
Lifu Sheng, Tessandra Stewart, Dishun Yang, Eric Thorland, David Soltys, Patrick Aro, Tarek Khrisat, Zhiying Xie, Na Li, Zongran Liu et al. · 2020 · Acta Neuropathologica Communications
Blood-brain barrier models: Rationale for selection
Amira Sayed Hanafy, Dirk Dietrich, Gert Fricker, Alf Lamprecht · 2021 · Advanced Drug Delivery Reviews
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
Wendy Balestri, Ruchi Sharma, Victor Allisson da Silva, Bianca Caroline Bobotis, Annabel J. Curle, Vandana Kothakota, Farnoosh Kalantarnia, Maria Victoria Hangad, Mina Hoorfar, Joanne Jones et al. · 2024 · Journal of Neuroinflammation
Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?
Antje Appelt‐Menzel, Sabrina Oerter, Sanjana Mathew, Undine Haferkamp, Carla Hartmann, Matthias Jung, Winfried Neuhaus, Ole Pleß · 2020 · Current Protocols in Stem Cell Biology
Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
Yamir Islam, Andrew G. Leach, Jayden A. Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James R. Downing, Amos A. Fatokun, Meritxell Teixidò, Touraj Ehtezazi · 2021 · Advanced Science
Understanding glucose metabolism and insulin action at the blood–brain barrier: Implications for brain health and neurodegenerative diseases
Yiyi Zhu, Alexei Verkhratsky, Hui Chen, Chenju Yi · 2025 · Acta Physiologica
Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease
Laura Pelizzari, Maria Marcella Laganà, Federica Rossetto, Niels Bergsland, M Galli, Giuseppe Baselli, Mario Clerici, Raffaello Nemni, Francesca Baglio · 2019 · Therapeutic Advances in Neurological Disorders
Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
Valery Danilenko, Andrey Devyatkin, Mariya Marsova, Madina Shibilova, Rustem Abuzarovich Ilyasov, Vladimir Shmyrev · 2021 · Journal of Inflammation Research
Potential crosstalk between sonic hedgehog‐WNT signaling and neurovascular molecules: Implications for blood–brain barrier integrity in autism spectrum disorder
Evelyne Gozal, Rekha Jagadapillai, Jun Cai, Gregory Neal Barnes · 2021 · Journal of Neurochemistry
Brain‐targeting drug delivery systems
Peixin Liu, Chen Jiang · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Efflux proteins at the blood–brain barrier: review and bioinformatics analysis
M. Saidijam, Fatemeh Karimi Dermani, Sareh Sohrabi, S. Patching · 2018 · Xenobiotica; the fate of foreign compounds in biological systems
Cannabidiol Protects Dopaminergic Neuronal Cells from Cadmium
Jacopo Junio Valerio Branca, Gabriele Morucci, Matteo Becatti, Donatello Carrino, Carla Ghelardini, Massimo Gulisano, Lorenzo Di Cesare Mannelli, Alessandra Pacini · 2019 · International Journal of Environmental Research and Public Health
Enlarged Perivascular Spaces and Age-Related Clinical Diseases
Yuyuan Yang, Meng Wang, Moxin Luan, Xiaoqian Song, Yajuan Wang, Lulu Xu, Meixiang Zhong, Xueping Zheng · 2023 · Clinical Interventions in Aging
Genetic networks in Parkinson’s and Alzheimer’s disease
Jack Kelly, Rana A. Moyeed, Camille Carroll, Shouqing Luo, Xinzhong Li · 2020 · Aging
Theranostic applications of metal–organic frameworks (MOFs)-based materials in brain disorders: Recent advances and challenges
Mehdi Bazi Alahri, Razieh Arshadizadeh, Mohammadali Raeisi, Mehrdad Khatami, Monireh Sadat Sajadi, Walid Kamal Abdelbasset, Ravil Akhmadeev, Siavash Iravani · 2021 · Inorganic Chemistry Communications
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, Matthieu Gracia, Aubin Pitiot, Caroline Denevault‐Sabourin, Nicolas Joubert, Jean‐Pierre Pouget, Valérie Gouilleux‐Gruart, Nathalie Heuzé‐Vourc'h et al. · 2021 · Pharmacology & Therapeutics
Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis
Yuen Yan Wong, Che‐Yuan Wu, Di Yu, Esther Kim, Melissa Wong, Renata Elez, Julia Zebarth, Michael Ouk, Jocelyn Tan, Jiamin Liao et al. · 2022 · Parkinsonism & Related Disorders
Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways
Stievenard, Alicia, Méquinion, Mathieu, Andrews, Zane B., Destée, Alain, Chartier-Harlin, Marie-Christine, Viltart, Odile, Vanbesien-Mailliot, Christel C. · 2017 · Neuroscience & Biobehavioral Reviews
Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease
Л. П. Долгачева, В. П. Зинченко, Nikolay V. Goncharov · 2022 · International Journal of Molecular Sciences
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases
Sephira G. Ryman, Andrei A. Vakhtin, Sarah Pirio Richardson, Henry C. Lin · 2022 · Journal of Neurology
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
Michael Poppell, Grace Hammel, Yi Ren · 2023 · International Journal of Molecular Sciences
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
Bang-rong Wei, Yujia Zhao, Yufeng Cheng, Chun Huang, Feng Zhang · 2024 · Immunity & Ageing
Interleukin-4 Contributes to Degeneration of Dopamine Neurons in the Lipopolysaccharide-treated Substantia Nigrain vivo
Eugene Bok, Eun Ju Cho, Eun Sook Chung, Won-Ho Shin, Byung Kwan Jin · 2018 · Experimental Neurobiology
l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease
Jessica L. Billings, Sarah L. Gordon, Tristan Rawling, Philip Doble, Ashley Ian Bush, Paul Anthony Adlard, David Isaac Finkelstein, Dominic James Hare · 2019 · Journal of Neurochemistry
T cells, α-synuclein and Parkinson disease
Francesca Garretti, Connor Monahan, Alessandro Sette, Dritan Agalliu, David Sulzer · 2022 · Handbook of clinical neurology
Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development
Atharva R. Mulay, Ji‐Hyun Hwang, Deok‐Ho Kim · 2024 · Advanced Healthcare Materials
Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia
Vincent A. Jourdain, Chris C. Tang, Florian Holtbernd, Christian Dresel, Yoon Young Choi, Yilong Ma, VIJAY M. DHAWAN, David Eidelberg · 2016 · JCI Insight
α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis
Laura M. Butkovich, Madelyn C. Houser, Malú G. Tansey · 2018 · Frontiers in Neuroscience
Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP
Mia San Miguel, Kristy L. Martin, Jonathan Stone, Daniel M. Johnstone · 2019 · Biomolecules
The neuromicrobiology of Parkinson’s disease: A unifying theory
Mario Muñoz, Nuno Empadinhas, Sandra M. Cardoso · 2021 · Ageing Research Reviews
Proteins and Transcriptional Dysregulation of the Brain Extracellular Matrix in Parkinson’s Disease: A Systematic Review
Wote Amelo Rike, Shani Stern · 2023 · International Journal of Molecular Sciences
The impact of α-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells
Hamdam Hourfar, Farhang Aliakbari, Shabboo Rahimi Aqdam, Zahra Nayeri, Hassan Bardania, Daniel E. Otzen, Dina Morshedi · 2022 · International Journal of Biological Macromolecules
Glial cells: an important switch for the vascular function of the central nervous system
Ling Gao, Xuezhen Pan, John H. Zhang, Ying Xia · 2023 · Frontiers in Cellular Neuroscience
Mercury in the retina and optic nerve following prenatal exposure to mercury vapor
Roger Pamphlett, Stephen Kum Jew, Svetlana Cherepanoff · 2019 · PLoS ONE
Protective Role of Capsaicin in Neurological Disorders: An Overview
Sakshi Tyagi, Nikhila Shekhar, Ajit Kumar Thakur · 2022 · Neurochemical Research
Immune-related biomarkers for Parkinson's disease
Ilham Y. Abdi, Simona S. Ghanem, Omar M. A. El‐Agnaf · 2022 · Neurobiology of Disease
Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches
Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, Soi Moi Chye · 2023 · CNS & Neurological Disorders - Drug Targets
Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier
Eduardo Cazalla, Antonio Cuadrado, Ángel J. García‐Yagüe · 2024 · Fluids and Barriers of the CNS
The Role of Microglia and Astrocytes in the Pathomechanism of Neuroinflammation in Parkinson’s Disease—Focus on Alpha-Synuclein
Oliwia Harackiewicz, Beata Grembecka · 2024 · Journal of Integrative Neuroscience
Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease
Shubhra Acharya, Antonio Salgado‐Somoza, Francesca Maria Stefanizzi, Andrew I. Lumley, Lu Zhang, Enrico Glaab, Patrick May, Yvan Devaux · 2020 · International Journal of Molecular Sciences
What a gastrointestinal biopsy can tell us about Parkinson's disease?
Anne-Gaëlle Corbillé, Thomas Clairembault, Emmanuel Coron, Laurène Leclair‐Visonneau, Cécile Preterre, Michel Neunlist, Pascal Derkinderen · 2016 · Neurogastroenterology & Motility
Brain pericyte activation occurs early in Huntington's disease
Thomas Padel, Michaela Roth, Abderahim Gaceb, Jiayi Li, Maria Björkqvist, Gesine Paul · 2018 · Experimental Neurology
Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?
Cristina Salado-Manzano, Unai Perpiñá, Marco Straccia, Francisco J. Molina-Ruiz, Emanuele Cozzi, Anne Rosser, Josep Maria Canals · 2020 · Frontiers in Cellular Neuroscience
Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases
Adriana Jiménez, Enrique Estudillo, Mara A. Guzmán‐Ruiz, Nieves Herrera, Georgina Victoria-Acosta, Enoc Mariano Cortés-Malagón, Adolfo López-Ornelas · 2025 · Pharmaceutics
Nrf2–Keap1 Pathway and NLRP3 Inflammasome in Parkinson’s Disease: Mechanistic Crosstalk and Therapeutic Implications
Ridhi Jain, Lalitkumar K. Vora, Deepak Nathiya, Dharmendra Kumar Khatri · 2025 · Molecular Neurobiology
Undetectable gadolinium brain retention in individuals with an age‐dependent blood‐brain barrier breakdown in the hippocampus and mild cognitive impairment
Axel Montagne, Mikko T. Huuskonen, Gautham Rajagopal, Melanie D. Sweeney, Daniel A. Nation, Farshid Sepehrband, Lina M. D’Orazio, Michael G. Harrington, Helena Chang Chui, Meng Law et al. · 2019 · Alzheimer s & Dementia
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease
Nouara Yahi, Coralie Di Scala, Henri Chahinian, Jacques Fantini · 2021 · Glycoconjugate Journal
Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
Taylor J. Stevenson, Rebecca H. Johnson, Jimmy Savistchenko, Justin Rustenhoven, Zoe Woolf, Leon C. D. Smyth, Helen C. Murray, Richard L. M. Faull, Jason A. Correia, Patrick M. Schweder et al. · 2022 · Scientific Reports
SOD2 Mediates Amifostine‐Induced Protection against Glutamate in PC12 Cells
Ji Jia, Lei Zhang, Xiaolei Shi, Mingchun Wu, Xiang Zhou, Xiaonan Liu, Tingting Huo · 2015 · Oxidative Medicine and Cellular Longevity
Reducing INS-IGF1 signaling protects against non-cell autonomous vesicle rupture caused by SNCA spreading
Carl Alexander Sandhof, Simon Oliver Hoppe, Silke Druffel‐Augustin, Christian Gallrein, Janine Kirstein, Cindy Voisine, Carmen I. Nussbaum-Krammer · 2019 · Autophagy
Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage
Elisa Vázquez-Liébanas, Giuseppe Mocci, Weihan Li, Bàrbara Laviña, Avril Reddy, Claire O’Connor, Natalie Hudson, Zaher Elbeck, Ioannis Nikoloudis, Konstantin Gaengel et al. · 2024 · Cell Reports
Therapeutic perspective on vascular cognitive impairment
Kensuke Toyama, Joshua Michael Spin, Masaki Mogi, Philip S. Tsao · 2019 · Pharmacological Research
The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
Jeswinder Sian‐Hülsmann, Peter Franz Riederer · 2021 · Cells
Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L.
Gemma Margetts, Sotirios Kleidonas, Nawel S. Zaibi, Mohamed Sghaier Zaibi, Kieron D. Edwards · 2022 · BMC Complementary Medicine and Therapies
Using multi-organ culture systems to study Parkinson’s disease
Orly Reiner, Tamar Sapir, Arpan Parichha · 2020 · Molecular Psychiatry
Hidden phenotypes of PINK1/Parkin knockout mice
Swagatika Paul, Alicia M. Pickrell · 2021 · Biochimica et Biophysica Acta (BBA) - General Subjects
Non-Invasive Evaluation of Cerebral Microvasculature Using Pre-Clinical MRI: Principles, Advantages and Limitations
Bram Callewaert, Elizabeth A. V. Jones, Uwe Himmelreich, Willy Gsell · 2021 · Diagnostics
Intranigral Administration of β ‐Sitosterol‐ β ‐D‐Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra
Claudia Luna-Herrera, Irma Alicia Martínez-Dávila, Luis Oskar Soto-Rojas, Yazmin Montserrat Flores-Martinez, Manuel A. Fernandez-Parrilla, José Ayala-Dávila, Bertha Alicia León‐Chávez, Guadalupe Soto-Rodríguez, Víctor Manuel Blanco-Álvarez, Francisco E. López-Salas et al. · 2020 · Journal of Immunology Research
Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models
Junhyuk Woo, Hyesun Cho, YunHee Seol, Soon Ho Kim, Chanhyeok Park, Ali Yousefian-Jazi, Seung Jae Hyeon, Jung-Hee Lee, Hoon Ryu · 2021 · Antioxidants
The Complexity of the Blood-Brain Barrier and the Concept of Age-Related Brain Targeting: Challenges and Potential of Novel Solid Lipid-Based Formulations
Federica Sommonte, Ilaria Arduino, Giuseppe Francesco Racaniello, Antonio Lopalco, Angela Assunta Lopedota, Nunzio Denora · 2021 · Journal of Pharmaceutical Sciences
Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta
Valerio Taggi, Mario Riera‐Romo, Micheline Piquette‐Miller, Henriette E. Meyer zu Schwabedissen, Sibylle Neuhoff · 2022 · Pharmaceutics
Overview of blood-brain barrier dysfunction in methamphetamine abuse
Lu Pang, Yun Wang · 2023 · Biomedicine & Pharmacotherapy
Sarcopenia in Parkinson's disease: from pathogenesis to interventions
Meilin Gui, Lingling Lv, Shenglan Hu, Lixia Qin, Chunyu Wang · 2025 · Metabolism
MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson’s disease
Yi Fang, Luyan Gu, Jun Tian, Shaobing Dai, Ying Chen, Ran Zheng, Xiaoli Si, Chongyao Jin, Zhe Song, Yaping Yan et al. · 2020 · Aging
Brown rats on farmland
David Whyte Macdonald, Manuel Berdoy, Joanne P. Webster · 2015 · Oxford University Press eBooks
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
Arazu Sharif, John C.L. Mamo, Virginie Lam, Hani Al‐Salami, Armin Mooranian, Gerald Francis Watts, Roger Clarnette, Giuseppe Luna, Ryusuke Takechi · 2024 · Translational Neurodegeneration
New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
Jolene S.Y. Tan, Yinxia Chao, Olaf Rötzschke, Eng‐King Tan · 2020 · International Journal of Molecular Sciences
Neuroinflammation across the Spectrum of Neurodegenerative Diseases: Mechanisms and Therapeutic Frontiers
Karyme M. Alemán-Villa, David A. Armienta-Rojas, Josué Camberos-Barraza, Ángel Radamés Rábago-Monzón, Alejandro Camacho-Zamora, Juan Fidel Osuna‐Ramos, Javier A. Magaña‐Gómez, Alma Marlene Guadrón‐Llanos, Loranda Calderón-Zamora, Claudia Desireé Norzagaray-Valenzuela et al. · 2025 · NeuroImmunoModulation
REMOVED: Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy
Aruna Sharma, Dafin Fior Muresanu, Ranjana Patnaik, Preeti Kumaran Menon, Z. Ryan Tian, Seaab Sahib, Ala Nozari, José Vicente Lafuente, Anca Dana Buzoianu, Stephen D. Skaper et al. · 2021 · Progress in brain research
Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
Irene Sanchez-Mirasierra, Saurav Ghimire, Sergio Hernández-Díaz, Sandra‐Fausia Soukup · 2022 · Frontiers in Cell and Developmental Biology
A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
Giselle Prunell, Silvia Olivera‐Bravo · 2022 · Biomolecules
Towards early detection of neurodegenerative diseases: A gut feeling
Stephanie Makdissi, Brendon Parsons, Francesca Di Cara · 2023 · Frontiers in Cell and Developmental Biology
Plasma ubiquitin C-terminal hydrolase L1 levels reflect disease stage and motor severity in Parkinson’s disease
Adeline Su Lyn Ng, Yi Jayne Tan, Zhonghao Lu, Ebonne Yulin Ng, Samuel Yong‐Ern Ng, Nicole Shuang Yu Chia, Fiona Setiawan, Zheyu Xu, Nicole Chwee Har Keong, Kay Yaw Tay et al. · 2020 · Aging
Novel therapeutic opportunities for neurodegenerative diseases with mesenchymal stem cells: the focus on modulating the blood-brain barrier
Vargas-Rodríguez, Pablo, Cuenca-Martagón, Alejandro, Castillo-González, Julia, Serrano-Martínez, Ignacio, Luque, Raúl M., Delgado, Mario, González-Rey, Elena · 2023 · International Journal of Molecular Sciences
Mitochondrial Dysfunction in Endothelial Progenitor Cells: Unraveling Insights from Vascular Endothelial Cells
Azra Kulovic‐Sissawo, Carolina Tocantins, Mariana S. Diniz, Elisa Weiß, Andreas J. Steiner, Silvija Tokic, Corina T. Madreiter‐Sokolowski, Susana P. Pereira, Ursula Hiden · 2024 · Biology
Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease
Drobny, Alice, Ngo, Phuong A., Neurath, Markus F., Zunke, Friederike, López-Posadas, Rocío · 2021 · Frontiers in Medicine
Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and Parkinson’s Disease
Matthew R. Miller, Harold E. Landis, Robert E. Miller, Yousef Tizabi · 2024 · Cells
The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease
Kyu-Young Sim, Kyeong Chan Im, Sung‐Gyoo Park · 2020 · International Journal of Molecular Sciences
Blood–brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes?
Ritambhara Aryal, Adjanie Patabendige · 2021 · Open Biology
High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein
Fengju Jia, Ning Song, Weiwei Wang, Xixun Du, Yajing Chi, Hong Fu Jiang · 2018 · Frontiers in Aging Neuroscience
Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration
Alexander Lin, Niridu Jude Peiris, Harkirat Dhaliwal, Maria Hakim, Weizhen Li, Subramaniam Ganesh, Yogambha Ramaswamy, Sanjay Patel, Ashish Misra · 2021 · Cells
Dapagliflozin alleviated seizures and cognition impairment in pilocarpine induced status epilepticus via suppressing microglia-mediated neuroinflammation and oxidative stress.
Ying Liu, Yuhang Yu, Changling Chen, Xuling Wu, Qian Zheng, Xiangming Zhang, Lan Ye, Chun-Lin Zhang, Zhan-Hui Feng · 2025 · International Immunopharmacology
Cardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets
Pingjing Zheng, Wendi Yan, Yang-Nan Ding, Yang Zhang, Zhangwei Chen, Juying Qian, Junbo Ge · 2026 · Signal Transduction and Targeted Therapy
Blood brain barrier-on-a-chip to model neurological diseases
S.C. Reshma, Kizhakkepurakkal Balachandran Megha, S. Amir, S. Rukhiya, P.V. Mohanan · 2023 · Journal of Drug Delivery Science and Technology
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
Megan Ritson, Caroline P.D. Wheeler-Jones, Helen B. Stolp · 2024 · Journal of Neuroimmunology
Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cells
Shyanne Page, Ronak Patel, Snehal Raut, Abraham Jacob Al-Ahmad · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Associations between atherosclerosis and neurological diseases, beyond ischemia-induced cerebral damage
Dannia Colín‐Castelán, Silvio Zaina · 2019 · Reviews in Endocrine and Metabolic Disorders
The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases
Marialuisa Zedde, Rosario Pascarella · 2024 · Brain Sciences
Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in Parkinson’s disease
Elizaveta M. Gerasimova, Amke C. Beenen, Daniel V. Kachkin, Martin Regensburger, Sebastian Zundler, David B. Blumenthal, Gloria Lutzny‐Geier, Beate Winner, Iryna Prots · 2025 · npj Parkinson s Disease
Protective Effects of Complement Component 8 Gamma Against Blood-Brain Barrier Breakdown
Jong‐Heon Kim, Jin Han, Kyoungho Suk · 2021 · Frontiers in Physiology
Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson’s Disease
Eric A. Bancroft, Rahul Srinivasan · 2022 · Frontiers in Physiology
Microbiome influences on neuro-immune interactions in neurodegenerative disease
Kelly B. Menees, Brittney A. Otero, Malú G. Tansey · 2022 · International review of neurobiology
Potential Cross Talk between Autism Risk Genes and Neurovascular Molecules: A Pilot Study on Impact of Blood Brain Barrier Integrity
Rekha Jagadapillai, Xiaolu Qiu, Kshama Ojha, Zhu Li, Ayman S El-Baz, Shipu Zou, Evelyne Gozal, Gregory Neal Barnes · 2022 · Cells